BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2001
View Archived Issues
Amrad product pipeline update
Read More
2000 highlights reported for Cell Therapeutics
Read More
Shire reviews Q4 and year-end 2000 developments
Read More
Two studies demonstrate efficacy of ziprasidone in patients with schizoaffective disorder
Read More
Demegen's antimicrobial peptide shows efficacy against herpesviruses and Chlamydia
Read More
Antiinfective properties of Pharming's hLF reported; AM-Pharma licenses Pharming peptide technology
Read More
Cellegy accelerates filing for Anogesic in Canada
Read More
Ribozyme and Chiron begin phase II trial with Angiozyme for breast cancer
Read More
Botulinum toxin type A preparation proves safe and effective in axillary hyperhidrosis
Read More
Update on phase II trials with Nobex's oral insulin reported
Read More
Promising toxicity and pharmacokinetic findings emerge from phase Ia trial of doranidazole
Read More
Orally active small-molecule GnRH antagonists presented by Neurocrine Biosciences
Read More
Review of Aslera NDA rescheduled for April
Read More
Pentasaccharide registration submission and other important events at Sanofi-Synthelabo
Read More
Access reports positive phase III data for OraDisc canker sore treatment
Read More
AtheroGenics moves second product into clinical development
Read More
Phase II trials of SMART 1D10 antibody begin in non-Hodgkin's lymphoma
Read More
BASB113 polynucleotides and polypeptides for use as vaccines
Read More
Chlamydia polypeptide and use in DNA vaccines
Read More
Antibacterial quinolinecarboxylic acid derivatives in development at Wakunaga
Read More
Taisho presents new VEGF receptor antagonists with antiangiogenic/antitumor activity
Read More
Hybrigenics and Servier to identify new targets for anticancer drugs
Read More
New treatments for osteoporosis with an indole structure
Read More
Merck reports compounds with the ability to inhibit cytokine production or activity
Read More
Recent patent covers metabotropic glutamate receptor antagonists selective for group II/III
Read More
Sigma receptor ligands and use as antipsychotics, etc., reported by Sanofi-Synthelabo
Read More
Dihydrobenzodiazepines and use in dyslipidemias, diabetes, etc.
Read More